NCT02285101View on ClinicalTrials.gov

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
MelanomaProstate Adenocarcinoma
Interventions
BIOLOGICAL

PEG-BCT-100

Trial Locations (2)

90404

John Wayne Cancer Institute, Santa Monica

92111

California Cancer Associates for Research and Excellence, cCARE, San Diego

Sponsors

Collaborators (1)

Oncotherapeutics
All Listed Sponsors
collaborator

Oncotherapeutics

INDUSTRY

lead

Bio-Cancer Treatment International Limited

INDUSTRY